Eastwood Bio-Medical Canada Inc. (EBM.V)
CAD 0.65
(-7.14%)
CAD 0.65
(-7.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.88 Thousand | -4294.00 | -116.21 Thousand | -542.69 Thousand | -178.12 Thousand | -454.79 Thousand |
| Net Income | -546.59 Thousand | -149.87 Thousand | -603.59 Thousand | -852.43 Thousand | -577.32 Thousand | -861.97 Thousand |
| Depreciation & Amortization | 107.85 Thousand | 106.85 Thousand | 105.3 Thousand | 105.74 Thousand | 45.99 Thousand | 25.61 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 417.64 Thousand | 34.1 Thousand | 393.93 Thousand | 183.71 Thousand | 255.79 Thousand | 67.66 Thousand |
| Other non-cash items | 4218.00 | 4630.00 | -11.86 Thousand | 20.27 Thousand | 97.4 Thousand | 313.9 Thousand |
| Investing Cash Flow | - | -3005.00 | -5574.00 | - | -23.11 Thousand | 10 Thousand |
| Investments in PPE | -2.00 | -3005.00 | -5574.00 | - | -23.11 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 10 Thousand |
| Financing Cash Flow | -4503.00 | 26.27 Thousand | 20 Thousand | 40 Thousand | - | - |
| Debt repayment | -4503.00 | -31.53 Thousand | -20 Thousand | -40 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 57.8 Thousand | 20 Thousand | 40 Thousand | - | - |
| Accounts receivables | 124.00 | -8567.00 | 3675.00 | 69.34 Thousand | 145.83 Thousand | -306.12 Thousand |
| Accounts payables | 41.42 Thousand | 7317.00 | -6438.00 | 18.32 Thousand | 8549.00 | 12.83 Thousand |
| Inventory | - | 8567.00 | 379.48 Thousand | -827.00 | 107.46 Thousand | 361.53 Thousand |
| Other working capital | 376.09 Thousand | 26.78 Thousand | 17.21 Thousand | 96.87 Thousand | -6056.00 | -580.00 |
| Cash at beginning of period | 39.83 Thousand | 20.86 Thousand | 122.65 Thousand | 625.35 Thousand | 826.59 Thousand | 1.27 Million |
| Cash at end of period | 18.44 Thousand | 39.83 Thousand | 20.86 Thousand | 122.65 Thousand | 625.35 Thousand | 826.59 Thousand |
| Capital Expenditure | -2.00 | -3005.00 | -5574.00 | - | -23.11 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -21.39 Thousand | 18.97 Thousand | -101.78 Thousand | -502.69 Thousand | -201.24 Thousand | -444.79 Thousand |
| Free Cash Flow | -16.89 Thousand | -7299.00 | -121.78 Thousand | -542.69 Thousand | -201.24 Thousand | -454.79 Thousand |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -115.57 Thousand | -130.13 Thousand | -54.23 Thousand | -184.23 Thousand | -546.59 Thousand | -117.3 Thousand |
| Depreciation & Amortization | 26.63 Thousand | 26.63 Thousand | 26.63 Thousand | 26.96 Thousand | 107.85 Thousand | 26.96 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 62.09 Thousand | 105.67 Thousand | 15.98 Thousand | 183.47 Thousand | 417.64 Thousand | 78.24 Thousand |
| Other non-cash items | 9266.00 | 18.27 Thousand | 10.38 Thousand | -23.58 Thousand | 4218.00 | 9266.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 1.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 22.4 Thousand | -9304.00 | -11.19 Thousand | -4114.00 | -4503.00 | -7727.00 |
| Debt repayment | -22.4 Thousand | -9304.00 | -11.19 Thousand | -4503.00 | -4503.00 | -7727.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 22.4 Thousand | -9304.00 | -11.19 Thousand | 389.00 | - | -7727.00 |
| Accounts receivables | -3653.00 | 3847.00 | -23.17 Thousand | 10.33 Thousand | 124.00 | -15.55 Thousand |
| Accounts payables | -21.4 Thousand | 40.43 Thousand | -10.37 Thousand | -8755.00 | 41.42 Thousand | 7064.00 |
| Inventory | - | - | - | - | - | 91.87 Thousand |
| Other working capital | 21.05 Thousand | 61.39 Thousand | 49.53 Thousand | 181.89 Thousand | 376.09 Thousand | -5140.00 |
| Cash at beginning of period | 8190.00 | 6024.00 | 18.44 Thousand | 19.93 Thousand | 39.83 Thousand | 30.49 Thousand |
| Cash at end of period | 13.01 Thousand | 8190.00 | 6024.00 | 18.44 Thousand | 18.44 Thousand | 19.93 Thousand |
| Capital Expenditure | 1.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4825.00 | 2166.00 | -12.42 Thousand | -1489.00 | -21.39 Thousand | -10.55 Thousand |
| Free Cash Flow | -17.58 Thousand | 11.47 Thousand | -1234.00 | 2625.00 | -16.88 Thousand | -2828.00 |
INDOAMIN
SRECR
ADM
AIML
GTN
FTV